← 2026-10-22 edition · Sourced reporting
Published Oct 22, 2026, 3:54 PM Central · This version Oct 22, 2026, 3:54 PM Central · As of 2026-10-22
WHO and ILO add a way to check whether TB support actually reaches families
The October 21 framework asks countries to measure whether people with TB receive timely, adequate health and social support. It creates no automatic benefit. WHO cites catastrophic costs for 47% of treated people and households in countries with national cost surveys; that figure is not a result for every household worldwide. [1] [2] [3]
Read WHO’s TB care guidance, then ask your treatment service about any local financial or social-support route. No universal benefit application or individual eligibility is verified here; do not stop medicines without medical advice. →Global WHO October 21, 2026 announcement of a WHO–ILO social-protection monitoring framework. Older 2023 commitment and 2027 target are context. No new national entitlement, eligibility finding, payment or measured health outcome.
- 2 source records
- World Health Organization and International Labour Organization
- World Health Organization
Still open: No country-specific application, eligibility rule, funded entitlement, payment record or independent implementation evaluation. All open questions ↓
Reporting question · As of 2026-10-22
The question: What does the new WHO–ILO framework do for households facing the cost of TB care?
Global WHO October 21, 2026 announcement of a WHO–ILO social-protection monitoring framework. Older 2023 commitment and 2027 target are context. No new national entitlement, eligibility finding, payment or measured health outcome.
Global October 21 framework. Monitoring questions, not a payment sequence, measured improvement, common worldwide coverage rate or new entitlement.
Read the process as a table
| Component | Meaning | Evidence |
|---|---|---|
| Reach | Does support effectively reach people with TB? | [1] |
| Timing | Does the benefit arrive when the household needs it? | [1] |
| Adequacy | Is the package adequate and comprehensive? | [1] |
| What is not established | The framework and 2027 target do not award an individual benefit. | [3] |
Archive photograph · 2012-02-29 · Geneva, Switzerland
Understand the story.
The gap between a promise and support
The new framework gives countries a way to check whether people with TB are effectively reached by health and social benefits. Timing and adequacy matter: a program can exist while support arrives too late or fails to cover a household’s needs. The announcement offers measurement, not evidence that this gap has closed. [1]
Keep the cost figure in its surveyed scope
WHO cites 47% across countries that carried out national household cost surveys. That is a warning about financial hardship in that evidence base. The announcement supplies no single common survey year or complete country denominator, so this report does not chart it as a precise worldwide household rate. [2]
The 2027 target does not award a benefit
The goal dates to a 2023 commitment; the October 21 development is the monitoring framework. Countries have different benefit systems and data capacity. A family cannot use this release as proof of eligibility, a payment amount, an application deadline or a new funded entitlement. [3]
Ask the care service about the practical gap
A useful next conversation is which national or local support may cover transport, income loss or other care costs, and when it would arrive. This reporting has not verified a universal benefit office. WHO’s TB guidance remains available for care information and warns against stopping medicines early or without medical advice. [1] [4]
How we know4 scoped claims · 2 source recordsView evidence
Each claim keeps its full assertion, date, source passage and limits. Source counts describe records, not independent corroboration.
1.Measure effective protectionSupported
WHO and ILO announced a framework for monitoring whether people with TB receive health and social benefits that are timely, adequate and comprehensive.
- Scope
- Global WHO October 21, 2026 announcement of a WHO–ILO social-protection monitoring framework. Older 2023 commitment and 2027 target are context. No new national entitlement, eligibility finding, payment or measured health outcome.
- Evidence passage
- Opening paragraph; Kasaeva explanation of effective reach, timeliness, adequacy and comprehensiveness.
- As of
- 2026-10-22
- Limit
- Measurement approach, not a benefit award or implementation result.
Retrieved 2026-10-22T20:05:25.296Z · World Health Organization and International Labour Organization
Agency announcement of its own framework. Survey-country costs and older commitments do not establish a funded entitlement or actual payment.
2.The 47% figure has a boundaryAttributed
WHO’s announcement says 47% of people treated for TB and their households face catastrophic costs across countries that conducted national TB household cost surveys.
- Scope
- Global WHO October 21, 2026 announcement of a WHO–ILO social-protection monitoring framework. Older 2023 commitment and 2027 target are context. No new national entitlement, eligibility finding, payment or measured health outcome.
- Evidence passage
- Second paragraph: scope of national TB household cost surveys.
- As of
- 2026-10-22
- Limit
- The release provides no single common survey year or full country denominator; do not generalize to every household worldwide.
Retrieved 2026-10-22T20:05:25.296Z · World Health Organization and International Labour Organization
Agency announcement of its own framework. Survey-country costs and older commitments do not establish a funded entitlement or actual payment.
3.An older commitment, not a new entitlementSupported
The release recalls the 2023 UN commitment to a health and social-benefits package for all people with TB by 2027 and proposes phased monitoring across differing national systems.
- Scope
- Global WHO October 21, 2026 announcement of a WHO–ILO social-protection monitoring framework. Older 2023 commitment and 2027 target are context. No new national entitlement, eligibility finding, payment or measured health outcome.
- Evidence passage
- 2023 commitment paragraph and phased monitoring paragraph.
- As of
- 2026-10-22
- Limit
- A target and monitoring framework do not create a nationally funded benefit or prove payment.
Retrieved 2026-10-22T20:05:25.296Z · World Health Organization and International Labour Organization
Agency announcement of its own framework. Survey-country costs and older commitments do not establish a funded entitlement or actual payment.
4.Do not interrupt treatment unaidedSupported
WHO’s TB fact sheet warns that stopping medicines early or without medical advice can promote drug resistance.
- Scope
- Global WHO October 21, 2026 announcement of a WHO–ILO social-protection monitoring framework. Older 2023 commitment and 2027 target are context. No new national entitlement, eligibility finding, payment or measured health outcome.
- Evidence passage
- Treatment: do not stop medications early or without medical advice.
- As of
- 2026-10-22
- Limit
- General guidance; no individualized regimen or national benefits decision is supplied.
Retrieved 2026-10-22T20:05:25.478Z · World Health Organization
General TB guidance and older burden estimates; not country-specific social-benefit eligibility or individualized care.
What remains open.
- No country-specific application, eligibility rule, funded entitlement, payment record or independent implementation evaluation.
- The announcement does not supply a complete survey-country list, common survey year or denominator for the 47% figure. The older fact sheet uses a different rounded burden description; it is not a like-for-like update.
A revised original, changed scope, contrary record or current operational update would reopen these claims and the exact draft.
THIS STORY IN TIME
Keep the dates with the story.
- Reported development
- Evidence as of
- First retained publication
- This version published
Publication times are Central. A development date and an evidence date can differ. Missing dates remain unrecorded.